Faster New Drug Approval Times Are More Than Offset by Longer Clinical Times in U.S., According to Tufts Center for the Study of ...
BOSTON, July 16, 2020 (GLOBE NEWSWIRE) -- Although regulatory approval time for new drugs in the United States is shortening, the time needed, on average, to complete clinical development of those drugs is lengthening by a greater amount, leading to longer …